Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Partner: Eli Lilly and Company
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology United Kingdom
    New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Remote Mentoring Programs in RCC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
    Release Date:
    Partner: The Sharing Progress in Cancer Care (SPCC)
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Canada, USA
    NSCLC Oncogene Driver Considerations in Testing & Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology France, Germany